• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/15/23 10:20:00 AM ET
    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ANEB alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Sidoti & Company, LLC, Monday, August 14, 2023, Press release picture

    Presentation Schedule

    *All Times EST

    Wednesday, August 16, 2023 (Day 1)

    8:30-9:00

    Ohmyhome Ltd. (OMH)

    Hookipa Pharma Inc. (HOOK)

    *****

    9:15-9:45

    Loop Industries (LOOP)

    Zomedica Inc (ZOM)

    LEE Enterprises, Inc. (LEE)

    10:00-10:30

    Mativ Holdings, Inc. (MATV)

    DLH Holdings (DLHC)

    T2 Biosystems, Inc. (TTOO)

    10:45-11:15

    Near Intelligence (NIR)

    Surmodics Inc. (SRDX)

    L.B. Foster Company (FSTR)

    11:30-12:00

    IDACORP, Inc (IDA)

    Harvard Bioscience (HBIO)

    Citizens, Inc. (CIA)

    12:15-12:45

    Independence Contract Drilling (ICD)

    Personalis (PSNL)

    Silvercrest Asset Management Group Inc. (SAMG)

    1:00-1:30

    Ideal Power (IPWR)

    Anebulo Pharmaceuticals (ANEB)

    GEE Group (JOB)

    1:45-2:15

    Powell Industries, Inc. (POWL)

    MAIA Biotechnology, Inc. (MAIA)

    Rocky Mountain Chocolate (RMCF)

    2:30-3:00

    Innovative Solutions & Support (ISSC)

    Hillstream BioPharma, Inc. (HILS)

    Super League Gaming, Inc (SLGG)

    3:15-3:45

    Unisys Corporation (UIS)

    Markforged (MKFG)

    CaliberCos Inc. (CWD)

    4:00-4:30

    Sonim Technologies (SONM)

    KLX Energy Services Holdings (KLXE)

    Comstock Inc (LODE)

    1x1s Only

    (16th)

    DevvStream Inc. (DSTRF)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Paysign, Inc. (PAYS)

    *****

    *****

    *****

    *All Times EST

    Thursday, August 17, 2023 (Day 2)

    8:30-9:00

    *****

    AGBA Group (AGBA)

    *****

    9:15-9:45

    MtronPTI (MPTI)

    The Real Brokerage Inc (REAX)

    Splash Beverage Group (SBEV)

    10:00-10:30

    CLIQ Digital AG (CLIQ)

    LifeMD (LFMD)

    Mistras Group (MG)

    10:45-11:15

    Innovative Eyewear, Inc. (LUCY)

    CareCloud (CCLD)

    Granite Construction Inc. (GVA)

    11:30-12:00

    Shapeways (SHPW)

    Processa Pharmaceuticals (PCSA)

    Landsea Homes (LSEA)

    12:15-12:45

    *****

    Modular Medical (MODD)

    Sidus Space (SIDU)

    1:00-1:30

    Daktronics (DAKT)

    Kala Pharmaceuticals (KALA)

    Terran Orbital (LLAP)

    1:45-2:15

    SOBR Safe Inc. (SOBR)

    Xcel Brands (XELB)

    SYLA Technologies (SYT)

    2:30-3:00

    Intellicheck (IDN)

    Alpha Teknova, Inc. (TKNO)

    ClearOne, Inc. (CLRO)

    3:15-3:45

    AudioEye Inc (AEYE)

    Quince Therapeutics (QNCX)

    Astra Space (ASTR)

    4:00-4:30

    Iteris, Inc. (ITI)

    *****

    ARC Document Solutions (ARC)

    1x1s Only

    (17th)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Kelly Services, Inc. (KELYA)

    Paysign, Inc. (PAYS)

    Tennant Company (TNC)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed a sister company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the nearly 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 160 equities of which around 40 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 1,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC and Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/774189/Sidoti-Events-LLCs-Virtual-August-Micro-Cap-Conference

    Get the next $ANEB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANEB
    $DLHC
    $HBIO
    $HOOK

    CompanyDatePrice TargetRatingAnalyst
    Powell Industries Inc.
    $POWL
    4/27/2026$310.00Overweight
    Analyst
    Powell Industries Inc.
    $POWL
    1/23/2026$427.00Neutral
    Cantor Fitzgerald
    IDACORP Inc.
    $IDA
    1/20/2026$118.00Equal Weight → Underweight
    Wells Fargo
    IDACORP Inc.
    $IDA
    1/14/2026$144.00Overweight
    Barclays
    IDACORP Inc.
    $IDA
    12/16/2025$139.00Equal-Weight → Overweight
    Morgan Stanley
    Unisys Corporation New
    $UIS
    12/10/2025Outperform
    William Blair
    Innovative Solutions and Support Inc.
    $ISSC
    12/5/2025$16.00Buy
    Craig Hallum
    Personalis Inc.
    $PSNL
    12/2/2025$11.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

    MAIA's novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today provided a patient enrollment update for its ongoing pivotal Phase 3 trial, THIO-104, evaluating its novel telomere-targeting therapy as a third-line (3L) treatment for advanced non-small cell lung cancer (NSCLC). To date, 29 patients have been dosed among 34 activated trial sites in 6 foreign countries. Vlad Vitoc, M.D., Founder and Chief Executive Officer o

    6/4/26 9:45:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion

    Additional data from THIO-101 trial expansion studies may further support a potential Accelerated Approval filing with FDA FDA-cleared IND updates detail latest efficacy data and enriched manufacturing protocols CHICAGO, June 03, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared an amendment to update its investigational new drug (IND) application which enables MAIA to open U.S. enrollment for the expansion of the Phase 2 THIO-101 trial of its lead candidate, ateganosine, as

    6/3/26 9:45:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MAIA Biotechnology Announces Open Market Purchases by CEO and Director

    CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that its founder and CEO Vlad Vitoc, M.D. and Director Stan V. Smith, Ph.D. have increased their ownership positions through open market purchases. Approximately 72,700 shares of MAIA common stock were purchased by Dr. Vitoc on June 6, 2026, at an average common stock price of $1.3877. Approximately 75,000 shares of MAIA common stock were purchased by Dr. Smith on June 6, 2026, at an average common stock price of $1.336. "Our continuing investments underscore our stron

    6/2/26 9:45:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $41,217 worth of shares (7,494 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    6/3/26 4:39:42 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Vitoc Vlad bought $100,886 worth of shares (72,700 units at $1.39), increasing direct ownership by 8% to 976,121 units (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    6/2/26 9:02:16 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Smith Stan bought $100,200 worth of shares (75,000 units at $1.34) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    6/2/26 9:01:25 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst initiated coverage on Powell Inds with a new price target

    Analyst initiated coverage of Powell Inds with a rating of Overweight and set a new price target of $310.00

    4/27/26 8:36:54 AM ET
    $POWL
    Electrical Products
    Energy

    Cantor Fitzgerald initiated coverage on Powell Inds with a new price target

    Cantor Fitzgerald initiated coverage of Powell Inds with a rating of Neutral and set a new price target of $427.00

    1/23/26 8:20:35 AM ET
    $POWL
    Electrical Products
    Energy

    IdaCorp downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded IdaCorp from Equal Weight to Underweight and set a new price target of $118.00

    1/20/26 9:09:08 AM ET
    $IDA
    Electric Utilities: Central
    Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $41,217 worth of shares (7,494 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    6/3/26 4:39:42 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Vitoc Vlad bought $100,886 worth of shares (72,700 units at $1.39), increasing direct ownership by 8% to 976,121 units (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    6/2/26 9:02:16 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Smith Stan bought $100,200 worth of shares (75,000 units at $1.34) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    6/2/26 9:01:25 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    SEC Filings

    View All

    Harvard Bioscience Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - HARVARD BIOSCIENCE INC (0001123494) (Filer)

    6/2/26 4:01:17 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Unisys Corporation New filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - UNISYS CORP (0000746838) (Filer)

    6/2/26 8:04:49 AM ET
    $UIS
    EDP Services
    Technology

    SEC Form 11-K filed by Unisys Corporation New

    11-K - UNISYS CORP (0000746838) (Filer)

    5/29/26 4:27:07 PM ET
    $UIS
    EDP Services
    Technology

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Leadership Updates

    Live Leadership Updates

    View All

    Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

    Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next era of ultrasensitive MRD testing Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of Richard Chen, M.D., M.S., to the position of President. Dr. Chen will continue to serve as CMO of Personalis in addition to his new role. The appointment comes at a critical inflection point as Personalis transitions from a pioneering R&D powerhouse into a market leader in Minimal Residual Disease (MRD) testing. Under Dr. Chen's scientific l

    3/17/26 4:00:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Innovative Aerosystems Acquires Moog' S-TEC® Model 3100 Autopilot Product Line, Expanding Flight Control Portfolio

    Innovative Aerosystems (NASDAQ:ISSC) today announced it closed the acquisition of the Moog (NYSE:MOG) S-TEC® Model 3100 general aviation fixed wing autopilot product line, further strengthening the company's position as a leading provider of advanced avionics, flight control, and mission-critical aerospace systems for commercial, business, and military aircraft. The acquisition expands Innovative Aerosystems' integrated flight control capabilities and enhances its ability to deliver modernized, mission-ready solutions across both legacy and next-generation platforms. By incorporating the proven autopilot technology into its growing portfolio, the company will provide customers with greate

    2/23/26 8:30:00 AM ET
    $ISSC
    $MOG
    EDP Services
    Technology

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by HOOKIPA Pharma Inc.

    SC 13G/A - HOOKIPA Pharma Inc. (0001760542) (Subject)

    11/14/24 6:07:08 PM ET
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Surmodics Inc.

    SC 13G/A - SURMODICS INC (0000924717) (Subject)

    11/14/24 3:36:00 PM ET
    $SRDX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by IDACORP Inc.

    SC 13G/A - IDACORP INC (0001057877) (Subject)

    11/14/24 1:28:29 PM ET
    $IDA
    Electric Utilities: Central
    Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Financials

    Live finance-specific insights

    View All

    DNA X, Inc. Reports First Quarter 2026 Financial Results

    Closed sale of the Company's mobile device assets to NEXA in January 2026Completed the transfer of the operations of the phone and hotspot business to NEXAFocused on enhancing the DNA X trading platform to prepare the platform for its initial growth phaseSan Diego, California--(Newsfile Corp. - May 20, 2026) - DNA X, Inc. (NASDAQ:SONM), a provider of cryptocurrency trading services, today announced its financial results for the first quarter ended March 31, 2026. The company operates the DNA X AI trading platform business, and expects to launch an enhanced version to the public later this year. The platform is designed to harness advanced AI and machine learning technologies to automate inte

    5/20/26 5:00:00 PM ET
    $SONM
    Telecommunications Equipment
    Utilities

    Ideal Power Reports First Quarter 2026 Financial Results

    AUSTIN, Texas, May 14, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, reports results for its first quarter ended March 31, 2026."We had a strong start to the year as we initiated two additional projects with our lead Asia customer, signed a letter of intent with an industry partner to co-develop a B-TRAN®-enabled prototype for evaluation by a U.S. hyperscaler supporting the new NVIDIA Rubin Ultra 800V DC AI data center power distribution architecture, advanced Stellantis deliverables on schedule, and engaged on new opportuni

    5/14/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Innovative Aerosystems Reports Second Quarter Fiscal 2026 Results

    Innovative Solutions & Support, Inc. (NASDAQ:ISSC) dba Innovative Aerosystems and its subsidiaries ("IA") or the "Company", a leading provider of advanced avionic solutions for commercial, business, and military aviation markets, today announced its fiscal 2026 second quarter financial results for the three-month period ended March 31, 2026. SECOND QUARTER FISCAL 2026 HIGHLIGHTS (all comparisons versus the prior year period) Net sales of $22.4 million, +2.0% Gross profit of $11.4 million; gross margin of 51.1% Net Income of $3.4 million, or $0.19 per diluted share Adjusted Net Income(1) of $4.8 million, or $0.26 per diluted share EBITDA(1) of $5.9 million; Adjusted EBITDA

    5/14/26 9:00:00 AM ET
    $ISSC
    EDP Services
    Technology